News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novo Nordisk A/S (NVO) Recalls Batches of FelxPen, Penfill Insulin in Europe


10/25/2013 7:53:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Novo Nordisk A/S (NOVOB) recalled batches of its NovoMix 30 FlexPen and Penfill insulin after Europe’s drug regulator recommended patients not use the products to avoid dose variations. The world’s biggest insulin maker told the European Medicines Agency that a manufacturing defect caused some batches to contain 50 percent to 150 percent of the labeled amount of insulin. The Bagsvaerd, Denmark-based company couldn’t say which ones had incorrect dosages, Novo spokesman Mike Rulis said.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Reuters
Read at PharmaBiz
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES